EVUZAMITIDE
Cryopyrin-Associated Periodic Syndromes
National Institute of Allergy and Infectious Diseases (NIAID)protein_peptidePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Cryopyrin-Associated Periodic Syndromes cohort.
Same molecule, other indications
EVUZAMITIDE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →